Your browser doesn't support javascript.
loading
Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
Kato, Masashi; Hirakawa, Akihiro; Sato, Hiroyuki; Hanazawa, Ryoichi; Naito, Yushi; Tochigi, Kosuke; Sano, Tomoyasu; Ishida, Shohei; Funahashi, Yasuhito; Fujita, Takashi; Matsukawa, Yoshihisa; Hattori, Ryohei; Tsuzuki, Toyonori.
Afiliação
  • Kato M; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan. mk-kato@med.nagoya-u.ac.jp.
  • Hirakawa A; Division of Biostatistics and Data Science, Clinical Research Center, Tokyo Medical and Dental University Tokyo, Tokyo, Japan.
  • Sato H; Division of Biostatistics and Data Science, Clinical Research Center, Tokyo Medical and Dental University Tokyo, Tokyo, Japan.
  • Hanazawa R; Division of Biostatistics and Data Science, Clinical Research Center, Tokyo Medical and Dental University Tokyo, Tokyo, Japan.
  • Naito Y; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Tochigi K; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Sano T; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Ishida S; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Funahashi Y; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Fujita T; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Matsukawa Y; Department of Urology, Nagoya University Graduate School of Medicine, 65 Tsumai-cho, Showa-ku, Nagoya, Japan.
  • Hattori R; Department of Urology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan.
  • Tsuzuki T; Department of Surgical Pathology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, Japan. tsuzuki@aichi-med-u.ac.jp.
Int J Clin Oncol ; 26(4): 764-769, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33385274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma Intraductal não Infiltrante Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma Intraductal não Infiltrante Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article